Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study
- PMID: 18040028
- DOI: 10.1161/CIRCULATIONAHA.107.719005
Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study
Abstract
Background: The relation between endogenous testosterone concentrations and health in men is controversial.
Methods and results: We examined the prospective relationship between endogenous testosterone concentrations and mortality due to all causes, cardiovascular disease, and cancer in a nested case-control study based on 11 606 men aged 40 to 79 years surveyed in 1993 to 1997 and followed up to 2003. Among those without prevalent cancer or cardiovascular disease, 825 men who subsequently died were compared with a control group of 1489 men still alive, matched for age and date of baseline visit. Endogenous testosterone concentrations at baseline were inversely related to mortality due to all causes (825 deaths), cardiovascular disease (369 deaths), and cancer (304 deaths). Odds ratios (95% confidence intervals) for mortality for increasing quartiles of endogenous testosterone compared with the lowest quartile were 0.75 (0.55 to 1.00), 0.62 (0.45 to 0.84), and 0.59 (0.42 to 0.85), respectively (P<0.001 for trend after adjustment for age, date of visit, body mass index, systolic blood pressure, blood cholesterol, cigarette smoking, diabetes mellitus, alcohol intake, physical activity, social class, education, dehydroepiandrosterone sulfate, androstanediol glucuronide, and sex hormone binding globulin). An increase of 6 nmol/L serum testosterone ( approximately 1 SD) was associated with a 0.81 (95% confidence interval 0.71 to 0.92, P<0.01) multivariable-adjusted odds ratio for mortality. Inverse relationships were also observed for deaths due to cardiovascular causes and cancer and after the exclusion of deaths that occurred in the first 2 years.
Conclusions: In men, endogenous testosterone concentrations are inversely related to mortality due to cardiovascular disease and all causes. Low testosterone may be a predictive marker for those at high risk of cardiovascular disease.
Comment in
-
Testosterone making an entry into the cardiometabolic world.Circulation. 2007 Dec 4;116(23):2658-61. doi: 10.1161/CIRCULATIONAHA.107.740365. Circulation. 2007. PMID: 18056536 No abstract available.
-
Low testosterone and risk of premature death in older men: analytical and preanalytical issues in measuring circulating testosterone.Clin Chem. 2008 Jul;54(7):1110-2. doi: 10.1373/clinchem.2008.104901. Clin Chem. 2008. PMID: 18593960 No abstract available.
Similar articles
-
Serum Testosterone is Inversely and Sex Hormone-binding Globulin is Directly Associated with All-cause Mortality in Men.J Clin Endocrinol Metab. 2021 Jan 23;106(2):e625-e637. doi: 10.1210/clinem/dgaa743. J Clin Endocrinol Metab. 2021. PMID: 33059368
-
Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk).BMJ. 2001 Jan 6;322(7277):15-8. doi: 10.1136/bmj.322.7277.15. BMJ. 2001. PMID: 11141143 Free PMC article.
-
Low serum testosterone and mortality in older men.J Clin Endocrinol Metab. 2008 Jan;93(1):68-75. doi: 10.1210/jc.2007-1792. Epub 2007 Oct 2. J Clin Endocrinol Metab. 2008. PMID: 17911176 Free PMC article.
-
Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).J Natl Cancer Inst. 2005 May 18;97(10):755-65. doi: 10.1093/jnci/dji132. J Natl Cancer Inst. 2005. PMID: 15900045
-
Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition.Lancet. 2001 Mar 3;357(9257):657-63. doi: 10.1016/s0140-6736(00)04128-3. Lancet. 2001. PMID: 11247548
Cited by
-
Relationships between endogenous and exogenous testosterone and cardiovascular disease in men.Rev Endocr Metab Disord. 2022 Dec;23(6):1305-1322. doi: 10.1007/s11154-022-09752-7. Epub 2022 Oct 11. Rev Endocr Metab Disord. 2022. PMID: 36219323 Free PMC article. Review.
-
Cardio-oncology in advanced prostate cancer.Front Oncol. 2024 Jun 14;14:1386597. doi: 10.3389/fonc.2024.1386597. eCollection 2024. Front Oncol. 2024. PMID: 38947889 Free PMC article.
-
Risk of Ischemic Heart Disease and Stroke in Prostate Cancer Survivors: A Nationwide Study in South Korea.Sci Rep. 2020 Jun 25;10(1):10313. doi: 10.1038/s41598-020-67029-y. Sci Rep. 2020. PMID: 32587285 Free PMC article.
-
Testosterone replacement and prostate cancer.Indian J Urol. 2012 Apr;28(2):123-8. doi: 10.4103/0970-1591.98449. Indian J Urol. 2012. PMID: 22919126 Free PMC article.
-
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?Endocr Rev. 2012 Jun;33(3):314-77. doi: 10.1210/er.2012-1002. Epub 2012 Mar 20. Endocr Rev. 2012. PMID: 22433122 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical